Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Drug interactions and bleeding complications with rivaroxaban compared to warfarin

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: CARDONA, Mark (Attard, Malta)
  • Co-author(s): Mark George Cardona
    Francesca Wirth
    Anthony Serracino-Inglott
    Lilian M Azzopardi
  • Abstract:

    Background

    Compared to warfarin, the novel oral anticoagulant (NOAC) rivaroxaban has fewer potential drug-drug interactions (DDIs). However, there is conflicting evidence regarding bleeding complications. 

    Purpose

    To compare rivaroxaban and warfarin with respect to potential DDIs and incidence and severity of bleeding.  

    Methods

    Following ethics

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses